Skip to content
healthcare.dev

azelaic acid

NDC 68462-626, azelaic acid, gel, from Glenmark Pharmaceuticals Inc., USA.

Product NDC
68462-626
Status
Listed
Labeler
Glenmark Pharmaceuticals Inc., USA
Dosage form
GEL
Route
TOPICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204637
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68462-626 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AZELAIC ACID.15 g/g

Pharmacologic classes

Decreased Protein Synthesis [PE]; Decreased Sebaceous Gland Activity [PE]

Package NDCNDC-11Package
68462-626-52684620626521 TUBE in 1 CARTON (68462-626-52) / 50 g in 1 TUBE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0b5ab22e-c78a-4429-9a76-a4ba2d11fcde
  • NADAC price for package 68462062652

    GET /v1/drugs/nadac/68462062652

Use it

Look up 68462-626 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68462-626 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68462-626. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.